These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6141009)

  • 21. [Withdrawal symptoms after discontinuation of beta-adrenolytic drugs].
    Markiewicz A; Karel M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1452-5. PubMed ID: 2421274
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardial electrical instability after abrupt withdrawal of long-term administration of propranolol to guinea pigs.
    Dennis SC; Manning AS; Hearse DJ; Coltart DJ
    Clin Sci (Lond); 1980 Sep; 59(3):207-9. PubMed ID: 7191789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible association of nonlipophilic beta-blockers and acute psychosis.
    Sklar SJ; Huck LA
    Clin Pharm; 1983; 2(3):274-7. PubMed ID: 6136363
    [No Abstract]   [Full Text] [Related]  

  • 24. Reflections on beta-adrenergic receptor blockers and cocaine use. A case in point.
    Izquierdo Gómez MM; Domínguez-Rodríguez A; Gálvez Rodríguez M; Marrero Rodríguez F
    Rev Esp Cardiol; 2009 Apr; 62(4):455-6. PubMed ID: 19401135
    [No Abstract]   [Full Text] [Related]  

  • 25. Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers.
    Steinhert J; Pugh CR
    Br Med J; 1979 Mar; 1(6166):790. PubMed ID: 35266
    [No Abstract]   [Full Text] [Related]  

  • 26. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
    Kurt M
    Hepatology; 2011 Apr; 53(4):1411-2. PubMed ID: 21225642
    [No Abstract]   [Full Text] [Related]  

  • 27. [Withdrawal of preparations blocking beta-adrenergic receptors].
    Prichard BN; Bhattacharjee P; Tomlinson B; Walden RJ
    Ter Arkh; 1982; 54(11):38-45. PubMed ID: 6130620
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(5):746-61. PubMed ID: 6115528
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats.
    Brynne L; Paalzow LK; Karlsson MO
    J Pharmacol Exp Ther; 1999 Aug; 290(2):664-71. PubMed ID: 10411576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal.
    Kähkönen S; Bondarenko B; Lipsanen J; Zvartau E
    Int J Psychophysiol; 2007 Dec; 66(3):225-30. PubMed ID: 17761330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?
    Krag A; Bendtsen F; Møller S
    Hepatology; 2011 Jan; 53(1):370-1. PubMed ID: 20815016
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe hyperkalemia induced by propranolol.
    Mandić D; Nezić L; Skrbić R
    Med Pregl; 2014; 67(5-6):181-4. PubMed ID: 25033579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncardiac surgery in patients receiving propranolol. Case reports and recommended approach.
    Goldman L
    Arch Intern Med; 1981 Feb; 141(2):193-6. PubMed ID: 7458515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blockers as a cause of violent rapid eye movement sleep behavior disorder: a poorly recognized but common cause of violent parasomnias.
    Morrison I; Frangulyan R; Riha RL
    Am J Med; 2011 Jan; 124(1):e11. PubMed ID: 20887968
    [No Abstract]   [Full Text] [Related]  

  • 35. Rebound phenomena following withdrawal of long-term beta-adrenoceptor blockade.
    Hjemdahl P; Olsson G
    Acta Med Scand Suppl; 1982; 665():43-7. PubMed ID: 6130674
    [No Abstract]   [Full Text] [Related]  

  • 36. The Influence of prolonged beta-blockers treatment on male rabbit's sexual behavior and penile microcirculation.
    Grotthus B; Piasecki T; Pieśniewska M; Marszalik P; Kwiatkowska J; Skrzypiec-Spring M; Szelag A
    Int J Impot Res; 2007; 19(1):49-54. PubMed ID: 16688208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Have the problems of beta blockers been overrated?
    Harv Heart Lett; 2000 Aug; 10(12):4-5. PubMed ID: 10927641
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-blockers and depression.
    Xiong GL; Gagliardi JP; Jiang W
    Am J Psychiatry; 2010 Feb; 167(2):219; author reply 219-20. PubMed ID: 20123927
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug withdrawal syndromes-- a literature review.
    Hodding GC; Jann M; Ackerman IP
    West J Med; 1980 Nov; 133(5):383-91. PubMed ID: 7008358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-adrenergic blocking drugs in anxiety and stress.
    Noyes R
    Psychiatr Clin North Am; 1985 Mar; 8(1):119-32. PubMed ID: 2859576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.